MX2011008360A - Derivados de piridazinona sustituida con heteroarilo. - Google Patents
Derivados de piridazinona sustituida con heteroarilo.Info
- Publication number
- MX2011008360A MX2011008360A MX2011008360A MX2011008360A MX2011008360A MX 2011008360 A MX2011008360 A MX 2011008360A MX 2011008360 A MX2011008360 A MX 2011008360A MX 2011008360 A MX2011008360 A MX 2011008360A MX 2011008360 A MX2011008360 A MX 2011008360A
- Authority
- MX
- Mexico
- Prior art keywords
- pyridazinone derivatives
- heteroaryl substituted
- substituted pyridazinone
- derivatives
- medicaments
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
- A61K31/501—Pyridazines; Hydrogenated pyridazines not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Abstract
La presente invención trata de los derivados de piridazinona novedosos de la fórmula (I) en donde R', R2, R3 y R4 son como se definiera en la descripción y en las reivindicaciones, así como también sales y ésteres fisiológicamente aceptables de los mismos. Estos compuestos inhiben la PDE10A y se pueden utilizar como medicamentos.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP09153391 | 2009-02-23 | ||
PCT/EP2010/052116 WO2010094762A1 (en) | 2009-02-23 | 2010-02-19 | Heteroaryl substituted pyridazinone derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2011008360A true MX2011008360A (es) | 2011-08-24 |
Family
ID=42312870
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2011008360A MX2011008360A (es) | 2009-02-23 | 2010-02-19 | Derivados de piridazinona sustituida con heteroarilo. |
Country Status (15)
Country | Link |
---|---|
US (1) | US9187455B2 (es) |
EP (1) | EP2398795B1 (es) |
JP (1) | JP5518902B2 (es) |
KR (1) | KR101363091B1 (es) |
CN (1) | CN102325766B (es) |
AR (1) | AR075534A1 (es) |
AU (1) | AU2010215428B2 (es) |
BR (1) | BRPI1008007A2 (es) |
CA (1) | CA2749867C (es) |
ES (1) | ES2526251T3 (es) |
IL (1) | IL213983A (es) |
MX (1) | MX2011008360A (es) |
SG (1) | SG173671A1 (es) |
TW (1) | TW201033193A (es) |
WO (1) | WO2010094762A1 (es) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101730665B1 (ko) | 2009-02-05 | 2017-04-26 | 다케다 야쿠힌 고교 가부시키가이샤 | 피리다지논 화합물 |
US9150588B2 (en) | 2010-08-10 | 2015-10-06 | Takeda Pharmaceutical Company Limited | Substituted pyridazin-4(1H)-ones as phosphodiesterase 10A inhibitors |
SG192839A1 (en) | 2011-02-18 | 2013-09-30 | Allergan Inc | Substituted 6,7-dialkoxy-3-isoquinolinol derivatives as inhibitors of phosphodiesterase 10 (pde10a) |
WO2014071044A1 (en) | 2012-11-01 | 2014-05-08 | Allergan, Inc. | Substituted 6,7-dialkoxy-3-isoquinoline derivatives as inhibitors of phosphodiesterase 10 (pde10a) |
EA201591540A1 (ru) | 2013-02-21 | 2016-01-29 | Такеда Фармасьютикал Компани Лимитед | Способ получения производных пиридазинона |
PT3060550T (pt) * | 2013-10-21 | 2019-08-27 | Merck Patent Gmbh | Compostos de heteroarilo como inibidores de btk e utilizações dos mesmos |
US9200016B2 (en) | 2013-12-05 | 2015-12-01 | Allergan, Inc. | Substituted 6, 7-dialkoxy-3-isoquinoline derivatives as inhibitors of phosphodiesterase 10 (PDE 10A) |
CN103772352B (zh) * | 2014-01-16 | 2017-01-18 | 四川百利药业有限责任公司 | 哒嗪酮类衍生物及其制备方法和用途 |
US11034669B2 (en) | 2018-11-30 | 2021-06-15 | Nuvation Bio Inc. | Pyrrole and pyrazole compounds and methods of use thereof |
KR20230090078A (ko) | 2021-12-14 | 2023-06-21 | 안희철 | 무선태그 장치 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE355839T1 (de) * | 2002-09-09 | 2007-03-15 | Amgen Inc | 1,4,5-substituierte 1,2-dihydro-pyrazol-3-one and 3-alkoxy-1h-pyrazole derivate als tnf-alpha und interleukin senkende wirkstoffe zur behandlung von entzündungen |
CN100519552C (zh) | 2002-09-25 | 2009-07-29 | 宇部兴产株式会社 | 吡唑化合物 |
WO2005012485A2 (en) | 2003-07-31 | 2005-02-10 | Bayer Pharmaceuticals Corporation | Methods for treating diabetes and related disorders using pde10a inhibitors |
WO2007129183A2 (en) | 2006-05-02 | 2007-11-15 | Pfizer Products Inc. | Bicyclic heteroaryl compounds as pde10 inhibitors |
JP5501251B2 (ja) * | 2008-01-11 | 2014-05-21 | アルバニー モレキュラー リサーチ, インコーポレイテッド | Mch拮抗薬としての(1−アジノン)置換ピリドインドール類 |
SG171954A1 (en) * | 2008-12-04 | 2011-07-28 | Hoffmann La Roche | Pyridazinone derivatives |
-
2010
- 2010-02-16 US US12/705,988 patent/US9187455B2/en not_active Expired - Fee Related
- 2010-02-19 SG SG2011058278A patent/SG173671A1/en unknown
- 2010-02-19 JP JP2011550576A patent/JP5518902B2/ja not_active Expired - Fee Related
- 2010-02-19 CA CA2749867A patent/CA2749867C/en not_active Expired - Fee Related
- 2010-02-19 EP EP10711618.8A patent/EP2398795B1/en not_active Not-in-force
- 2010-02-19 AU AU2010215428A patent/AU2010215428B2/en not_active Ceased
- 2010-02-19 BR BRPI1008007A patent/BRPI1008007A2/pt not_active Application Discontinuation
- 2010-02-19 ES ES10711618.8T patent/ES2526251T3/es active Active
- 2010-02-19 WO PCT/EP2010/052116 patent/WO2010094762A1/en active Application Filing
- 2010-02-19 CN CN201080008620.XA patent/CN102325766B/zh not_active Expired - Fee Related
- 2010-02-19 MX MX2011008360A patent/MX2011008360A/es active IP Right Grant
- 2010-02-19 KR KR1020117019449A patent/KR101363091B1/ko not_active IP Right Cessation
- 2010-02-22 TW TW099105041A patent/TW201033193A/zh unknown
- 2010-02-22 AR ARP100100503A patent/AR075534A1/es unknown
-
2011
- 2011-07-07 IL IL213983A patent/IL213983A/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EP2398795B1 (en) | 2014-10-15 |
CA2749867A1 (en) | 2010-08-26 |
AR075534A1 (es) | 2011-04-06 |
US9187455B2 (en) | 2015-11-17 |
WO2010094762A1 (en) | 2010-08-26 |
EP2398795A1 (en) | 2011-12-28 |
JP5518902B2 (ja) | 2014-06-11 |
AU2010215428B2 (en) | 2016-06-23 |
IL213983A0 (en) | 2011-08-31 |
TW201033193A (en) | 2010-09-16 |
JP2012518619A (ja) | 2012-08-16 |
CN102325766A (zh) | 2012-01-18 |
KR20110111495A (ko) | 2011-10-11 |
IL213983A (en) | 2016-07-31 |
KR101363091B1 (ko) | 2014-02-13 |
CN102325766B (zh) | 2015-03-18 |
ES2526251T3 (es) | 2015-01-08 |
US20100216793A1 (en) | 2010-08-26 |
CA2749867C (en) | 2017-06-06 |
AU2010215428A1 (en) | 2011-08-11 |
BRPI1008007A2 (pt) | 2016-03-15 |
SG173671A1 (en) | 2011-09-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2012007536A (es) | Derivados de heteroarilo que contienen nitrogeno. | |
MX2011008360A (es) | Derivados de piridazinona sustituida con heteroarilo. | |
TW200833324A (en) | Sulfonamide derivatives | |
UA108105C2 (ru) | Азотсодержащие гетероарильные соединения | |
UA108640C2 (uk) | Похідні n-(імідазопіримідин-7-іл)гетероариламідів та їх застосування як інгібіторів pde10a | |
MX2009004441A (es) | Derivados de indazol utiles como inhibidores de las isoformas de higado. | |
TW200738655A (en) | Novel bicyclic sulfonamide derivatives | |
MX2009010218A (es) | Derivados de aza-piridopirimidinona. | |
MX2012003469A (es) | Derivados de imidazopiridina o imidazopirimidina como inhibidores fosfodiesterasa 10a. | |
MX2010002341A (es) | Derivados de bencimidazol usados como agonistas del receptor x de farnesoide. | |
TW200745032A (en) | Novel heterobicyclic derivatives | |
UA109037C2 (uk) | Триазолопіридини | |
GEP201706691B (en) | Substituted phthalazin-1 (2h)-one derivatives as selecti- ve inhibitors of poly (adp-ribose) polymerase-1 | |
MX2010006565A (es) | Derivados de benzimidazol sustituido por carboxilo o hidroxilo. | |
IN2012DN03337A (es) | ||
MX2010005827A (es) | Derivados de aminopirazol. | |
MX2011012739A (es) | Derivados fluorados de aminotriazol. | |
MX2010005824A (es) | Derivados de aminotiazol. | |
WO2009040289A3 (en) | Biaryl sulfonamide derivatives | |
MX2010009922A (es) | Activadores de piridazinona glucocinasa. | |
UA108711C2 (uk) | Сполуки триазолопіридину як інгібітори фосфодіестерази pde10a | |
UA97821C2 (en) | Cyclized derivatives as eg-5 inhibitors | |
MX2011013884A (es) | Sulfonamidas heterociclicas, usos y composiciones farmaceuticas de las mismas. | |
MX2010005164A (es) | Derivados de bencimidazol y su uso como agonistas del receptor x de farnesoide. | |
MX2010001742A (es) | Nuevos derivados de piperazina-amida. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |